At NeuroGen Brain and Spine Institute, stem cell treatment NuCulture for muscular dystrophy has shown remarkable results in patients with the similar condition. The success rate of progress in the treatment of muscular dystrophy at NeuroGen is around 90%, which is truly remarkable. This treatment has enabled a significant improvement in the patient to regain trunk muscle strength and limb strength.A study has revealed that Tetrathiomolybdate, a copper-sequestering drug, plays an important role in providing a treatment for Wilson disease, which is caused by an over accumulation of copper and metastatic cancers. Small info is available, however is known about how the drug works at the molecular level. A fresh research study conducted and guided by the Northwestern University researchers now has provided a priceless clue i.e the three-dimensional structure of TM bound to copper loaded metallochaperones. The tetrathiomolybdate sequester the chaperone and its bound copper, forbidding both from carrying out their normal functions in the cell. For those patients suffering from Wilson disease and other cancers whose primary growth is helped by copper-dependent angiogenesis, this is very promising.